88U

N-(4-methoxyphenyl)-N,2-dimethyl-quinazolin-4-amine

Created:	2017-05-18
Last modified:	2018-04-18

Find Related PDB Entry
1 entries where 88U is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	38
Chiral Atom Count	0
Bond Count	40
Aromatic Bond Count	17

2D diagram of 88U

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-(4-methoxyphenyl)-N,2-dimethyl-quinazolin-4-amine
Systematic Name (OpenEye OEToolkits)	~{N}-(4-methoxyphenyl)-~{N},2-dimethyl-quinazolin-4-amine
Formula	C₁₇ H₁₇ N₃ O
Molecular Weight	279.336
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	COc1ccc(cc1)N(C)c2nc(C)nc3ccccc23
SMILES	OpenEye OEToolkits	2.0.6	Cc1nc2ccccc2c(n1)N(C)c3ccc(cc3)OC
Canonical SMILES	CACTVS	3.385	COc1ccc(cc1)N(C)c2nc(C)nc3ccccc23
Canonical SMILES	OpenEye OEToolkits	2.0.6	Cc1nc2ccccc2c(n1)N(C)c3ccc(cc3)OC
InChI	InChI	1.03	InChI=1S/C17H17N3O/c1-12-18-16-7-5-4-6-15(16)17(19-12)20(2)13-8-10-14(21-3)11-9-13/h4-11H,1-3H3
InChIKey	InChI	1.03	SNHCRNMVYDHVDT-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB05585
Name	Verubulin
Groups	investigational
Description	Antineoplastic; a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps.
Synonyms	Verubulin Verubulin hydrochloride Varbulin
Indication	Investigated for use/treatment in brain cancer, lung cancer, melanoma, and solid tumors.
Categories	Heterocyclic Compounds, Fused-Ring
CAS number	827031-83-4

Related Resource References

Resource Name	Reference
Pharos	CHEMBL492399
PubChem	11414799
ChEMBL	CHEMBL492399

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.